Stockscreener 앱 받기
0.6246
6.82%
0.0399
시간 외 거래:
.62
-0.0046
-0.74%
Vyne Therapeutics Inc 주식(VYNE)의 최신 뉴스
VYNE SEC FilingsVyne Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Gains Report: Will VYNE Therapeutics Inc face regulatory challenges2026 Volume Leaders & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Aug Big Picture: What are analysts price targets for VYNE Therapeutics IncPortfolio Risk Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance - The Globe and Mail
VYNE Therapeutics Inc. Files Form 8-K: Notice of Delisting from NASDAQ and Company Information (March 11, 2026) - Minichart
VYNE Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq grants VYNE Therapeutics (VYNE) more time to fix sub-$1 share price - Stock Titan
Entry Recap: Can VYNE Therapeutics Inc sustain earnings growthOptions Play & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Aug Outlook: Can VYNE Therapeutics Inc expand its profit marginsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Dividend Watch: What is the long term forecast for VYNE Therapeutics Inc stockJuly 2025 Closing Moves & Stepwise Swing Trade Plans - baoquankhu1.vn
Vyne Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Technical Analysis: What analysts say about VYNE Therapeutics Inc stockJuly 2025 Trends & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
VYNE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
VYNE Should I Buy - Intellectia AI
VYNE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
VYNE: Losses narrowed in 2025 as the company pivots to a merger with Yarrow and exits key R&D programs - TradingView
VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
VYNE Therapeutics (VYNE) to Release Quarterly Earnings on Thursday - Defense World
Aug Analyst Calls: Is Magnite Inc on track to beat earningsWeekly Profit Analysis & Verified Technical Signals - baoquankhu1.vn
Financial Contrast: Qualigen Therapeutics and VYNE Therapeutics - National Today
How VYNE Therapeutics Inc. stock performs in rate cut cyclesWatch List & Consistent Income Trade Recommendations - mfd.ru
Reviewing Avalo Therapeutics (NASDAQ:AVTX) and VYNE Therapeutics (NASDAQ:VYNE) - Defense World
Why is VYNE Therapeutics Inc. stock going upTrade Signal Summary & Proven Capital Preservation Methods - mfd.ru
VYNE Therapeutics Inc. (NASDAQ:VYNE) Sees Large Decline in Short Interest - Defense World
Published on: 2026-02-14 10:12:41 - mfd.ru
What analysts say about VYNE Therapeutics Inc. stockWeekly Stock Analysis & Accurate Intraday Trading Signals - mfd.ru
Can VYNE Therapeutics Inc. deliver consistent dividendsJuly 2025 Highlights & Detailed Earnings Play Alerts - mfd.ru
Published on: 2026-02-12 18:59:51 - mfd.ru
Can VYNE Therapeutics Inc. benefit from deglobalizationPortfolio Update Report & Capital Efficient Trading Techniques - mfd.ru
Published on: 2026-02-09 22:57:29 - baoquankhu1.vn
What analysts say about VYNE Therapeutics Inc stockEarnings Growth Summary & Smart Money Movement Tracker - baoquankhu1.vn
Portfolio Recap: Why is VYNE Therapeutics Inc stock going upBuy Signal & Reliable Momentum Entry Alerts - baoquankhu1.vn
Trade Report: What is the long term forecast for VYNE Therapeutics Inc stockInflation Watch & High Conviction Buy Zone Alerts - baoquankhu1.vn
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience - The Globe and Mail
Does MTCH stock have upside surprise potentialQuarterly Trade Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
VYNE Therapeutics Signs Amendment to Merger Agreement With Yarrow Bioscience - TradingView
Breakout Zone: Is VYNE Therapeutics Inc stock showing strong momentumTrade Performance Summary & Stock Market Timing Techniques - baoquankhu1.vn
How cyclical is VYNE Therapeutics Inc.’s revenue stream2025 Winners & Losers & Long-Term Growth Portfolio Plans - mfd.ru
Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Decreases By 55.4% - Defense World
Support Test: Can SunCar Technology Group Inc. scale operations efficientlyMarket Movers & Verified Swing Trading Watchlists - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Block Trades: Is VersaBank a potential multi baggerJuly 2025 Institutional & Technical Buy Zone Confirmations - baoquankhu1.vn
Is Sonoco Products Company exposed to currency risksMarket Growth Report & Verified Entry Point Signals - baoquankhu1.vn
Volume Summary: Is VYNE Therapeutics Inc stock showing strong momentumWeekly Risk Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Analysis Recap: What is the long term forecast for VYNE Therapeutics Inc stockQuarterly Growth Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Weekly Earnings: Is SEALPRB stock a value trapJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Aug EndMonth: Why is VYNE Therapeutics Inc stock going upWeekly Gains Report & Fast Momentum Entry Tips - baoquankhu1.vn
Is VYNE Therapeutics Inc. stock positioned well for digital economyJuly 2025 Pullbacks & Safe Entry Trade Reports - Улправда
Will VYNE Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Trends & AI Enhanced Trading Alerts - Улправда
US Stocks Recap: Will VYNE Therapeutics Inc stock remain a Wall Street favoriteJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - Bộ Nội Vụ
What insider trading reveals about VYNE Therapeutics Inc. stockJuly 2025 Chart Watch & Reliable Breakout Forecasts - ulpravda.ru
VYNE Therapeutics Inc. (NASDAQ:VYNE) Short Interest Down 18.2% in December - Defense World
VYNE Therapeutics Inc. (VYNE) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vyne Therapeutics shares surge on merger deal with Yarrow Bioscience - MSN
Why VYNE Therapeutics Inc. stock remains resilient2025 EndofYear Setup & Entry Point Confirmation Signals - Улправда
VYNE Therapeutics to merge with Yarrow Bioscience, secures $200M financing; shares up - MSN
Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
1.20%
0.06%
자본화:
|
볼륨(24시간):